ATE335739T1 - Cak inhibitoren und deren verwendungen - Google Patents
Cak inhibitoren und deren verwendungenInfo
- Publication number
- ATE335739T1 ATE335739T1 AT02729350T AT02729350T ATE335739T1 AT E335739 T1 ATE335739 T1 AT E335739T1 AT 02729350 T AT02729350 T AT 02729350T AT 02729350 T AT02729350 T AT 02729350T AT E335739 T1 ATE335739 T1 AT E335739T1
- Authority
- AT
- Austria
- Prior art keywords
- cak
- inhibitors
- compositions
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29623901P | 2001-06-06 | 2001-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE335739T1 true ATE335739T1 (de) | 2006-09-15 |
Family
ID=23141198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02729350T ATE335739T1 (de) | 2001-06-06 | 2002-06-06 | Cak inhibitoren und deren verwendungen |
Country Status (7)
Country | Link |
---|---|
US (1) | US7078209B2 (de) |
EP (1) | EP1399442B1 (de) |
JP (1) | JP2005501009A (de) |
AT (1) | ATE335739T1 (de) |
DE (1) | DE60213802T2 (de) |
ES (1) | ES2266497T3 (de) |
WO (1) | WO2002098876A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2838123B1 (fr) * | 2002-04-04 | 2005-06-10 | Sanofi Synthelabo | Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf |
FR2859997B1 (fr) * | 2003-09-18 | 2006-02-03 | Sanofi Synthelabo | Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant. |
EP1888063B1 (de) * | 2005-05-18 | 2009-01-14 | F2G Ltd. | Antimykotische mittel |
GB0623209D0 (en) | 2006-11-21 | 2007-01-03 | F2G Ltd | Antifungal agents |
GB0710121D0 (en) | 2007-05-25 | 2007-07-04 | F2G Ltd | Antifungal agents |
DK2283006T3 (en) | 2008-04-24 | 2015-05-26 | F2G Ltd | Pyrrole-based antifungal agents |
WO2012160464A1 (en) | 2011-05-26 | 2012-11-29 | Daiichi Sankyo Company, Limited | Heterocyclic compounds as protein kinase inhibitors |
EP2912036A1 (de) | 2012-10-04 | 2015-09-02 | Pfizer Limited | Pyrrolo[3,2-d-]pyrimidin-tropomyosin-vermittelte kinasehemmer |
SI3221308T1 (sl) | 2014-11-21 | 2018-12-31 | F2G Limited | Antimikotiki |
GB201609222D0 (en) | 2016-05-25 | 2016-07-06 | F2G Ltd | Pharmaceutical formulation |
CN106632322B (zh) * | 2016-12-20 | 2018-08-03 | 南京师范大学 | 一类吡唑中氮茚化合物及其制备方法与用途 |
US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3913682A1 (de) | 1989-04-26 | 1990-10-31 | Bayer Ag | 3-aryl-pyrrolidin-2,4-dione |
AU622330B2 (en) | 1989-06-23 | 1992-04-02 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides |
US5705350A (en) * | 1995-08-29 | 1998-01-06 | Duke University | Transcription factor complexes in senescent cells |
-
2002
- 2002-06-06 DE DE60213802T patent/DE60213802T2/de not_active Expired - Lifetime
- 2002-06-06 WO PCT/US2002/018102 patent/WO2002098876A1/en active IP Right Grant
- 2002-06-06 JP JP2003501997A patent/JP2005501009A/ja not_active Withdrawn
- 2002-06-06 ES ES02729350T patent/ES2266497T3/es not_active Expired - Lifetime
- 2002-06-06 US US10/166,234 patent/US7078209B2/en not_active Expired - Fee Related
- 2002-06-06 EP EP02729350A patent/EP1399442B1/de not_active Expired - Lifetime
- 2002-06-06 AT AT02729350T patent/ATE335739T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20030119793A1 (en) | 2003-06-26 |
JP2005501009A (ja) | 2005-01-13 |
ES2266497T3 (es) | 2007-03-01 |
EP1399442B1 (de) | 2006-08-09 |
US7078209B2 (en) | 2006-07-18 |
DE60213802T2 (de) | 2007-03-29 |
WO2002098876A1 (en) | 2002-12-12 |
DE60213802D1 (de) | 2006-09-21 |
EP1399442A1 (de) | 2004-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE433447T1 (de) | Pyrimiidinverbindungen | |
SE0101675D0 (sv) | Novel composition | |
DE60142921D1 (de) | Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren | |
EA200401157A1 (ru) | N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv | |
DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
DE60214703D1 (de) | Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen | |
PL406680A1 (pl) | Inhibitory kinaz tyrozynowych | |
BRPI0418251A (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais | |
ATE433980T1 (de) | Gyraseinhibitoren und deren verwendungen | |
YU37904A (sh) | Benzimidazoli kao korisni inhibitori proteinske kinaze | |
BG66084B1 (bg) | Циклопентаноиндоли, състави,съдържащи такива съединения и използването им | |
ATE417051T1 (de) | Polymorphe von clopidogrel-hydrogensulfat | |
BRPI0413234A (pt) | derivados de imidazola bicìclica contra flaviviridae | |
ATE466860T1 (de) | Cgrp-rezeptorantagonisten | |
DE60214179D1 (de) | IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN | |
ATE413388T1 (de) | Muskarin antagonisten | |
ES2243579T3 (es) | Derivados de pirazolopirideno. | |
MXPA03011546A (es) | Formulacion farmaceutica. | |
DE50208918D1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
ATE349448T1 (de) | Pyrazol-3,4-d-pyrimidinderivate und ihre verwendung bei der behandlung von h.pylori- infektionen | |
ATE335739T1 (de) | Cak inhibitoren und deren verwendungen | |
DK1373220T3 (da) | Benzimidazoler, som er nyttige ved behandling af seksuel dysfunktion | |
BR0318521A (pt) | arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados | |
ATE443044T1 (de) | Tace inhibitoren | |
ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |